Events Calendar

Mon
Tue
Wed
Thu
Fri
Sat
Sun
M
T
W
T
F
S
S
1
2
3
4
5
6
7
9
11
12
13
14
16
17
19
20
21
27
28
1
2
3
4
5
6
7
Psychiatry and Psychological Disorders
2021-02-08 - 2021-02-09    
All Day
Mental health Summit 2021 is a meeting of Psychiatrist for emerging their perspective against mental health challenges and psychological disorders in upcoming future. Psychiatry is [...]
Nanotechnology and Materials Engineering
2021-02-10 - 2021-02-11    
All Day
Nanotechnology and Materials Engineering are forthcoming use in healthcare, electronics, cosmetics, and other areas. Nanomaterials are the elements with the finest measurement of size 10-9 [...]
Dementia, Alzheimers and Neurological Disorders
2021-02-10 - 2021-02-11    
All Day
Euro Dementia 2021 is a distinctive forum to assemble worldwide distinguished academics within the field of professionals, Psychology, academic scientists, professors to exchange their ideas [...]
Neurology and Neurosurgery 2021
2021-02-10 - 2021-02-11    
All Day
European Neurosurgery 2021 anticipates participants from all around the globe to experience thought provoking Keynote lectures, oral, video & poster presentations. This Neurology meeting will [...]
Biofuels and Bioenergy 2021
2021-02-15 - 2021-02-16    
All Day
Biofuels and Bioenergy biofuel is a fuel that is produced through contemporary biological processes, such as agriculture and anaerobic digestion, rather than a fuel produced [...]
Tropical Medicine and Infectious Diseases
2021-02-15 - 2021-02-16    
All Day
Tropical Disease Webinar committee members invite all the participants across the globe to take part in this conference covering the theme “Global Impact on infectious [...]
Infectious Diseases 2021
2021-02-15 - 2021-02-16    
All Day
Infection Congress 2021 is intended to honor prestigious award for talented Young Researchers, Scientists, Young Investigators, Post-Graduate Students, Post-Doctoral Fellows, Trainees in recognition of their [...]
Gastroenterology and Liver Diseases
2021-02-18 - 2021-02-19    
All Day
Gastroenterology and Liver Diseases Conference 2021 provides a chance for all the stakeholders to collect all the Researchers, principal investigators, experts and researchers working under [...]
World Kidney Congress 2021
2021-02-18    
All Day
Kidney Meet 2021 will be the best platform for exchanging new ideas and research. It’s a virtual event that will grab the attendee’s attention to [...]
Agriculture & Organic farming
2021-02-22 - 2021-02-23    
All Day
                                                  [...]
Aquaculture & Fisheries
2021-02-22 - 2021-02-23    
All Day
We take the pleasure to invite all the Scientist, researchers, students and delegates to Participate in the Webinar on 13th World Congress on Aquaculture & [...]
Nanoscience and Nanotechnology 2021
2021-02-22 - 2021-02-23    
All Day
Conference Series warmly invites all the participants across the globe to attend "5th Annual Meet on Nanoscience and Nanotechnology” dated on February 22-23, 2021 , [...]
Neurology, Psychiatric disorders and Mental health
2021-02-23 - 2021-02-24    
12:00 am
Neurology, Psychiatric disorders and Mental health Summit is an idiosyncratic discussion to bring the advanced approaches and also unite recognized scholastics, concerned with neurology, neuroscience, [...]
Food and Nutrition 2021
2021-02-24    
All Day
Nutri Food 2021 reunites the old and new faces in food research to scale-up many dedicated brains in research and the utilization of the works [...]
Psychiatry and Psychological Disorders
2021-02-24 - 2021-02-25    
All Day
Mental health Summit 2021 is a meeting of Psychiatrist for emerging their perspective against mental health challenges and psychological disorders in upcoming future. Psychiatry is [...]
International Conference on  Biochemistry and Glyco Science
2021-02-25 - 2021-02-26    
All Day
Our point is to urge researchers to spread their test and hypothetical outcomes in any case a lot of detail as could be ordinary. There [...]
Biomedical, Biopharma and Clinical Research
2021-02-25 - 2021-02-26    
All Day
Biomedical research 2021 provides a platform to enhance your knowledge and forecast future developments in biomedical, bio pharma and clinical research and strives to provide [...]
Parasitology & Infectious Diseases 2021
2021-02-25    
All Day
INFECTIOUS DISEASES CONGRESS 2021 on behalf of its Organizing Committee, assemble all the renowned Pathologists, Immunologists, Researchers, Cellular and Molecular Biologists, Immune therapists, Academicians, Biotechnologists, [...]
Tissue Science and Regenerative Medicine
2021-02-26 - 2021-02-27    
All Day
Tissue Science 2021 proudly invites contributors across the globe to attend “International Conference on Tissue Science and Regenerative Medicine” during February 26-27, 2021 (Webinar) which [...]
Infectious Diseases, Microbiology & Beneficial Microbes
2021-02-26 - 2021-02-27    
All Day
Infectious diseases are ultimately caused by microscopic organisms like bacteria, viruses, fungi or parasites where Microbiology is the investigation of these minute life forms. A [...]
Stress Management 2021
2021-02-26    
All Day
Stress Management Meet 2021 will be a great platform for exchanging new ideas and research. It’s an online event which will grab the attendee’s attention [...]
Heart Care and Diseases 2021
2021-03-03    
All Day
Euro Heart Conference 2020 will join world-class professors, scientists, researchers, students, Perfusionists, cardiologists to discuss methodology for ailment remediation for heart diseases, Electrocardiography, Heart Failure, [...]
Gastroenterology and Digestive Disorders
2021-03-04 - 2021-03-05    
All Day
Gastroenterology Diseases is clearing a worldwide stage by drawing in 2500+ Gastroenterologists, Hepatologists, Surgeons going from Researchers, Academicians and Business experts, who are working in [...]
Environmental Toxicology and Ecological Risk Assessment
2021-03-04 - 2021-03-05    
All Day
Environmental Toxicology 2021 you can meet the world leading toxicologists, biochemists, pharmacologists, and also the industry giants who will provide you with the modern inventions [...]
Dermatology, Cosmetology and Plastic Surgery
2021-03-05 - 2021-03-06    
All Day
Market Analysis Speaking Opportunities Speaking Opportunities: We are constantly intrigued by hearing from professionals/practitioners who want to share their direct encounters and contextual investigations with [...]
Events on 2021-02-08
Events on 2021-02-18
Events on 2021-02-24
Events on 2021-03-03
Events on 2021-03-05
Funding

Healthcare-IT Sector Could get $784 MN VC Funding in Q1

criteria

Transaction Valued at Approximately $5.3 Billion or $48.75 Per Share

The Permira Funds Partner with Canada Pension Plan Investment Board to Acquire World’s Number One Independent Enterprise Data Integration Provider

REDWOOD CITY, Calif., April 7, 2015 (GLOBE NEWSWIRE) — Informatica Corporation (Nasdaq:INFA) (the “Company”), the world’s number one independent provider of enterprise data integration software and services, today announced that it has entered into a definitive agreement to be acquired by a company controlled by the Permira funds and Canada Pension Plan Investment Board (CPPIB) for approximately $5.3 billion.

Under the terms of the agreement, Informatica shareholders will receive $48.75 in cash for each share of Informatica common stock.

Informatica is acknowledged as a leader in several technology categories, including Cloud Integration, Data Integration for Big Data initiatives, and MDM Solutions. Informatica’s three-pronged growth strategy is to expand across all major geographic regions, grow across all customer data initiatives, and advance technology leadership in all things data.

“After careful consideration and deliberation of strategic alternatives, our Board of Directors unanimously concluded that the sale of Informatica to the Permira funds and CPPIB is in the best interest of all Informatica stakeholders,” said Sohaib Abbasi, chairman and chief executive officer, Informatica. “While delivering immediate compelling value to our shareholders, we remain committed to the long-term success of our customers, partners, and employees. Permira and CPPIB share both our vision for Informatica to power the data-ready enterprise and our conviction in sustained long-term growth.”

“Informatica is an outstanding company and a clear leader in the essential field of enterprise data solutions,” said Brian Ruder, a Permira Partner and Co-Head of the firm’s Technology Sector Team. “We are very excited about the Company’s ongoing transition to cloud and subscription based services, as well as its continued pursuit of four separate billion dollar market opportunities in cloud integration, master data management, data integration for next generation analytics, and data security. In addition, we look forward to working with this talented team of dedicated employees and CPPIB to grow the business and achieve Informatica’s highest potential.”

“This transaction represents an excellent opportunity to acquire a market-leading enterprise data integration solutions provider,” said Mark Jenkins, Senior Managing Director & Global Head of Private Investments, CPPIB. “Informatica’s differentiated suite of software solutions, stable base of recurring revenues and strong potential for future growth make this a highly attractive investment for CPPIB. We look forward to partnering with the Informatica team and the Permira funds to accelerate the Company’s growth and to support Informatica’s continued market leadership in product innovation.”

Informatica’s Board of Directors has unanimously approved the merger agreement and resolved to recommend that Informatica shareholders adopt the agreement. The transaction is expected to be completed in either the second or third quarter of 2015, subject to receipt of shareholder approval and customary regulatory approvals, as well as satisfaction of other customary closing conditions.

Qatalyst Partners acted as financial advisor to Informatica and Wilson Sonsini Goodrich & Rosati acted as legal counsel.

BofA Merrill Lynch, Goldman, Sachs & Co., Macquarie Capital, and Union Square Advisors LLC served as financial advisors to the Permira funds and CPPIB while Fried, Frank, Harris, Shriver & Jacobson LLP served as legal advisors. BofA Merrill Lynch, Credit Suisse, Goldman Sachs, Macquarie Capital, Morgan Stanley, Nomura, and RBC Capital Markets are serving as joint bookrunners on the financing. CPPIB was also separately advised by Torys LLP.

About Informatica

Informatica Corporation (Nasdaq:INFA) is the world’s number one independent provider of enterprise data integration software and services. Organizations around the world rely on Informatica to realize their information potential and drive top business imperatives. Informatica Vibe, the industry’s first and only embeddable virtual data machine (VDM), powers the unique “Map Once. Deploy Anywhere.” capabilities of the Informatica Platform. Worldwide, over 5,500 enterprises depend on Informatica to fully leverage their information assets from devices to mobile to social to big data residing on-premise, in the Cloud and across social networks. For more information, call +1 650-385-5000 (1-800-653-3871 in the U.S.), or visit www.informatica.com.

About Permira

Permira is an international private equity firm. The Permira funds, raised from pension funds and other institutions, make long-term investments in companies with the ambition of transforming their performance and driving sustainable growth. Founded in 1985, the firm advises funds with a total committed capital of approximately €25 billion and has made over 200 private equity investments.

Permira specializes in five key sectors: Consumer, Financial Services, Healthcare, Industrials and Technology and its portfolio currently comprises over 25 companies. Permira employs over 120 professionals based in Dubai, Frankfurt, Guernsey, Hong Kong, London, Luxembourg, Madrid, Menlo Park, Milan, New York, Paris, Seoul, Stockholm and Tokyo.

Permira established itself in North America in 2002 and today has offices in New York and Menlo Park.  The Permira funds have a long track record of successfully investing in technology companies around the world including NDS, Genesys, Ancestry.com, TeamViewer, Renaissance Learning, Metalogix, LegalZoom.com, and Teraco.  Since 1997, over 33% of the Permira funds’ investments have been in the core sector of Technology.

About CPPIB

Canada Pension Plan Investment Board (CPPIB) is a professional investment management organization that invests the funds not needed by the Canada Pension Plan (CPP) to pay current benefits on behalf of 18 million contributors and beneficiaries. In order to build a diversified portfolio of CPP assets, CPPIB invests in public equities, private equities, real estate, infrastructure and fixed income instruments. Headquartered in Toronto, with offices in Hong Kong, London, New York City, São Paulo, CPPIB is governed and managed independently of the Canada Pension Plan and at arm’s length from governments. At December 31, 2014, the CPP Fund totalled C$238.8 billion. For more information about CPPIB, please visit www.cppib.com.

Forward-Looking Statements

Statements about the expected timing, completion and effects of the proposed transaction and all other statements in this release, other than historical facts, constitute forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Readers are cautioned not to place undue reliance on these forward-looking statements and any such forward-looking statements are qualified in their entirety by reference to the following cautionary statements. All forward-looking statements speak only as of the date hereof and are based on current expectations and involve a number of assumptions, risks and uncertainties that could cause the actual results to differ materially from such forward-looking statements. Informatica may not be able to complete the proposed transaction on the terms described above or other acceptable terms or at all because of a number of factors, including the failure to obtain stockholder approval or the failure to satisfy the closing conditions. Factors that may affect the business or financial results of Informatica are described in the risk factors included in Informatica’s filings with the Securities and Exchange Commission (the “SEC”), including Informatica’s 2014 Annual Report on Form 10-K and later filed quarterly reports on Form 10-Q and Current Reports on Form 8-K, which factors are incorporated herein by reference. Informatica expressly disclaims a duty to provide updates to forward-looking statements, whether as a result of new information, future events or other occurrences.

Additional Information and Where to Find It

In connection with the proposed transaction, Informatica will file with the SEC and furnish to Informatica’s stockholders a proxy statement. Stockholders are urged to read the proxy statement when it becomes available because it will contain important information about the proposed transaction. Investors and security holders may obtain a free copy of documents filed by Informatica with the SEC at the SEC’s website at http://www.sec.gov. In addition, investors and security holders may obtain a free copy of Informatica’s filings with the SEC from Informatica’s website at http://investor.informatica.com/financial-info/sec-filings/default.aspx or by directing a request to: Informatica Corporation, 2100 Seaport Blvd, Redwood City, CA, 94063, Attn: Investor Relations, (650) 385-5261.

Informatica and certain of its directors, executive officers and affiliates may be deemed to be participants in the solicitation of proxies from stockholders of Informatica in favor of the proposed merger. Information about the directors and executive officers of Informatica is set forth in the proxy statement for Informatica’s 2014 annual meeting of stockholders, as filed with the SEC on Schedule 14A on April 8, 2014. Additional information regarding the interests of these individuals and other persons who may be deemed to be participants in the solicitation will be included in the proxy statement Informatica will file with the SEC.

For Informatica:
Debbie O'Brien
Global Communications
650-385-5735 - office
650-995-6736 - mobile

For Informatica:
Stephanie Wakefield
Investor Relations
650-385-5261

For Permira:
Noemie de Andia
Head of Communications
+44 20 7632 1159

For CPPIB:
Mei Mavin
Director, Corporate Communications
+44 20 3205 3515

Or

Sard Verbinnen & Co
Brooke Gordon/Nathaniel Garnick
+1 (212) 687-8080
Megan Bouchier
+1 (415) 618-8750

Source